Sale of Securities

Adaptimmune Therapeutics PLC Filed 2025-01-15 Acc 0001970051-25-000002

Documents 1

2025-01-15 144 Sale of Securities
2025-01-15 144 Sale of Securities
2025-01-15 144 Sale of Securities
2025-01-15 4 Chief Executive Officer sold 59,569 shares at an average $0.58 ($34,639)
2025-01-15 4 Chief Commercial Officer sold 12,991 shares at $0.57 ($7,467)
2025-01-15 4 Chief Medical Officer sold 22,195 shares at an average $0.58 ($12,920)
2025-01-15 4 Chief Patient Supply Officer sold 19,542 shares at an average $0.58 ($11,360)

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…